Sopharma AD researches and develops, produces, and trades in medicinal substances, finished drug forms, veterinary vaccines, infusion solutions, and plastic medical disposable products for human and veterinary medicine, and food supplements in Bulgaria and internationally. It offers products in various therapeutic areas, such as cardiology, gastroenterology, pain management, cough and cold, immunology and dermatology, respiratory and asthma, neurology and psychiatry, urology, and gynecology. The company's products comprise Carsil to treat gastroenterological disorders; Tempalgin, an analgesic; Tabex, a plant-based drug used for smoking secession; Tribestan, a plant-based drug used for stimulation of functions of the sexual system; Broncholytin, which is used to suppress cough; Analgin, a generic analgesic; Nivalin, a plant-based product used for diseases of the peripheral nervous system; and Methylprednisolon, a general medicine for cases of severe allergies and life-threatening conditions. It also trades in food supplements; provides secondary packaging services for pharmaceutical products and real estate leases; trades, transports, and packages radioactive materials and nuclear equipment for medicinal use, household electronics, and electrical equipment; and purchases, collects, grows, produces, and trades in herbs and medicinal plants. In addition, the company engages in the retail trade of medicinal products and medical equipment; production of non-medicinal, and other products; and franchising, know-how, and rental of properties, as well as in trading, consulting, and other activities. Further, it offers market and public opinion research services; and engages in non-pharma activities, such as veterinary vaccines, infusion solutions. Sopharma AD was founded in 1933 and is headquartered in Sofia, Bulgaria.
We bring innovation, health and well-being to our customers through world-class integrated pharmaceutical technologies and products. We strive to achieve excellent performance in all areas of business and to create value for our customers, shareholders, society, employees and partners.
Pelagia Stefanova Viatcheva (Director of Investor Relations)
E. Joffe (Director of Quality Management & Regulatory Compliance)
Mr. Alexandar Yotov (Head of Legal Department)
E. Krasteva (Director of Advter. & Corp. Communications)
Lyudmila Bondzhova (Head of Reporting Department)
E. Mihailova (Head of Production Division)
S. Katzarova (Head of Regulatory Affairs Bulgaria & Third Markets Division)
Sopharma is proud to have been recognized for the quality of its products and services. Most notably, it received the Award of Excellence from the Global Forum for Health Research in 2017 and the Award of Recognition from the European Federation of Pharmaceutical Industries and Associations in 2016.
